loading
Merit Medical Systems, Inc. stock is currently priced at $73.78, with a 24-hour trading volume of 279.30K. It has seen a +0.55% increased in the last 24 hours and a +1.19% rose in the past month. The chart indicates a potential bullish trend, as the stock is above the $73.47 pivot point. If it approaches the $74.14 resistance level, significant changes may occur.
Previous Close:
$73.38
Open:
$73.4
24h Volume:
279.30K
Market Cap:
$4.28B
Revenue:
$1.26B
Net Income/Loss:
$94.41M
P/E Ratio:
42.65
EPS:
1.73
Net Cash Flow:
$108.45M
1W Performance:
+2.43%
1M Performance:
+1.19%
6M Performance:
+16.21%
1Y Performance:
-5.01%
1D Range:
Value
$73.40
$74.21
52W Range:
Value
$62.58
$85.62

Merit Medical Systems, Inc. Stock (MMSI) Company Profile

Name
Name
Merit Medical Systems, Inc.
Name
Phone
801-253-1600
Name
Address
1600 West Merit Parkway, South Jordan, UT
Name
Employee
5,600
Name
Twitter
@meritmedical
Name
Next Earnings Date
2024-04-30
Name
Latest SEC Filings
Name
MMSI's Discussions on Twitter

Merit Medical Systems, Inc. Stock (MMSI) Upgrades & Downgrades

Date Action Analyst Rating Change
Feb-07-24 Initiated BofA Securities Neutral
Dec-21-23 Upgrade Canaccord Genuity Hold → Buy
Dec-20-22 Downgrade Canaccord Genuity Buy → Hold
Jan-05-21 Upgrade Needham Hold → Buy
Sep-28-20 Upgrade Wells Fargo Underweight → Equal Weight
Feb-25-20 Downgrade Barrington Research Outperform → Mkt Perform
Feb-03-20 Upgrade Raymond James Mkt Perform → Outperform
Dec-12-19 Downgrade Wells Fargo Market Perform → Underperform
Sep-24-19 Initiated Oppenheimer Outperform
Sep-10-19 Downgrade Raymond James Outperform → Mkt Perform
Jul-26-19 Downgrade Needham Buy → Hold
Jul-26-19 Downgrade Wells Fargo Outperform → Market Perform
Oct-02-18 Reiterated Needham Buy
Aug-07-18 Downgrade BofA/Merrill Buy → Underperform
Jul-24-18 Reiterated Needham Buy
Jun-01-18 Reiterated Needham Buy
May-18-18 Reiterated SunTrust Buy
Apr-26-18 Reiterated Needham Buy
Apr-20-18 Initiated Needham Buy
Mar-01-18 Upgrade Barrington Research Mkt Perform → Outperform
Aug-28-17 Downgrade Raymond James Strong Buy → Outperform
Jul-20-17 Initiated BofA/Merrill Buy
Jun-20-17 Initiated SunTrust Buy
Apr-05-17 Initiated Wells Fargo Outperform
View All

Merit Medical Systems, Inc. Stock (MMSI) Financials Data

Merit Medical Systems, Inc. (MMSI) Revenue 2024

MMSI reported a revenue (TTM) of $1.26 billion for the quarter ending December 31, 2023, a +9.24% rise year-over-year.
loading

Merit Medical Systems, Inc. (MMSI) Net Income 2024

MMSI net income (TTM) was $94.41 million for the quarter ending December 31, 2023, a +26.70% increase year-over-year.
loading

Merit Medical Systems, Inc. (MMSI) Cash Flow 2024

MMSI recorded a free cash flow (TTM) of $108.45 million for the quarter ending December 31, 2023, a +64.10% increase year-over-year.
loading

Merit Medical Systems, Inc. (MMSI) Earnings per Share 2024

MMSI earnings per share (TTM) was $1.63 for the quarter ending December 31, 2023, a +25.38% growth year-over-year.
loading

Merit Medical Systems, Inc. Stock (MMSI) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Wright Joseph
CHIEF COMMERCIAL OFFICER
Mar 07 '24
Option Exercise
28.20
25,000
705,000
67,223
Wright Joseph
CHIEF COMMERCIAL OFFICER
Mar 07 '24
Sale
75.68
25,000
1,891,925
42,223
Peterson Neil
CHIEF OPERATING OFFICER
Mar 06 '24
Option Exercise
44.80
7,500
336,000
14,819
Gunderson Thomas James
Director
Mar 04 '24
Option Exercise
34.40
25,000
860,000
37,414
Gunderson Thomas James
Director
Mar 04 '24
Sale
76.03
18,157
1,380,513
19,257
Evans Stephen C.
Director
Mar 04 '24
Sale
76.35
1,000
76,348
7,226
Millner F. Ann
Director
Jan 22 '24
Option Exercise
34.40
20,000
688,000
49,960
Millner F. Ann
Director
Jan 22 '24
Sale
80.00
20,000
1,600,000
29,960
LAMPROPOULOS FRED P
PRESIDENT AND CEO
Aug 25 '23
Option Exercise
28.20
200,000
5,640,000
1,167,916
LAMPROPOULOS FRED P
PRESIDENT AND CEO
Aug 25 '23
Option Exercise
28.20
6,000
169,200
12,888
Merit Medical Systems, Inc. designs, develops, manufactures, and markets various disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. The company operates through Cardiovascular and Endoscopy segments. It provides various peripheral intervention products, including access, angiography, intervention, and drainage and biopsy products to alleviate patients suffering from peripheral vascular and non-vascular diseases; and cardiac intervention products to aid in the treatment of various cardiac conditions specific to interventional cardiology and electrophysiology, including cardiac rhythm management and lead management. The company also offers cardiovascular and critical care products comprising infection prevention and safety, and fluid management and monitoring devices. In addition, it provides interventional oncology and spine products, such as vertebral compression fractures; tumor ablation systems; inflation syringes; microspheres for treating hypervascularized tumors and liver cancer; polyvinyl alcohol particles to treat hypervascularized tumors; and microcatheters for the controlled and selective infusion of diagnostic, embolic, or therapeutic agents into vessels. Further, the company offers endoscopy products, such as non-vascular stents, esophageal stents, biliary stent systems, esophageal balloon dilators, inflation devices, and guide wires; and kits and accessories for endoscopy and bronchoscopy procedures. Additionally, it provides coated tubes and wires; and microelectromechanical systems sensor components. The company sells its products to hospitals and clinic-based physicians, technicians, and nurses through its direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. Merit Medical Systems, Inc. was founded in 1987 and is headquartered in South Jordan, Utah.
medical_instruments_supplies ATR
$143.33
price up icon 2.25%
medical_instruments_supplies TFX
$206.71
price up icon 0.00%
medical_instruments_supplies COO
$88.84
price down icon 1.21%
$75.98
price up icon 0.36%
medical_instruments_supplies BAX
$40.13
price down icon 0.25%
medical_instruments_supplies WST
$360.43
price down icon 2.10%
Cap:     |  Volume (24h):